MX2019008589A - Composicion de dieta para la prevencion y/o el tratamiento para la hiperplasia endometrial. - Google Patents

Composicion de dieta para la prevencion y/o el tratamiento para la hiperplasia endometrial.

Info

Publication number
MX2019008589A
MX2019008589A MX2019008589A MX2019008589A MX2019008589A MX 2019008589 A MX2019008589 A MX 2019008589A MX 2019008589 A MX2019008589 A MX 2019008589A MX 2019008589 A MX2019008589 A MX 2019008589A MX 2019008589 A MX2019008589 A MX 2019008589A
Authority
MX
Mexico
Prior art keywords
prevention
treatment
endometrial hyperplasia
diet
administered
Prior art date
Application number
MX2019008589A
Other languages
English (en)
Inventor
Nencioni Alessio
Caffa Irene
Longo Valter
becherini Pamela
Original Assignee
Univ Degli Studi Genova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Genova filed Critical Univ Degli Studi Genova
Publication of MX2019008589A publication Critical patent/MX2019008589A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Una composición de dieta para utilizarse en la prevención y/o el tratamiento de la hiperplasia endometrial en un sujeto humano, que comprende a) un componente de dieta que imita el ayuno, a ser administrado durante un primer periodo de tiempo y que proporciona menos de 50% de la ingesta calórica normal del sujeto con restricción de proteínas y restricción de azúcar; y b) un componente de dieta de realimentación, a ser administrado durante un segundo periodo de tiempo, que proporciona 60-100% de la ingesta calórica normal del sujeto, en donde el componente de dieta que imita el ayuno y el componente de dieta de realimentación se administran durante múltiples ciclos.
MX2019008589A 2017-01-26 2018-01-23 Composicion de dieta para la prevencion y/o el tratamiento para la hiperplasia endometrial. MX2019008589A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000008499A IT201700008499A1 (it) 2017-01-26 2017-01-26 Composizione dietetica per la prevenzione e/o il trattamento dell’iperplasia dell’endometrio
PCT/EP2018/051590 WO2018138090A1 (en) 2017-01-26 2018-01-23 Diet composition for the prevention and/or the treatment of endometrial hyperplasia

Publications (1)

Publication Number Publication Date
MX2019008589A true MX2019008589A (es) 2019-11-21

Family

ID=58995077

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019008589A MX2019008589A (es) 2017-01-26 2018-01-23 Composicion de dieta para la prevencion y/o el tratamiento para la hiperplasia endometrial.

Country Status (12)

Country Link
US (1) US20190380373A1 (es)
EP (1) EP3573481B1 (es)
JP (1) JP2020505921A (es)
KR (1) KR20190126783A (es)
CN (1) CN110402087A (es)
AU (1) AU2018212440A1 (es)
BR (1) BR112019015302A2 (es)
CA (1) CA3051634A1 (es)
IT (1) IT201700008499A1 (es)
MX (1) MX2019008589A (es)
RU (1) RU2019116827A (es)
WO (1) WO2018138090A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111093396A (zh) * 2017-09-12 2020-05-01 雀巢产品有限公司 用于模拟长期热量限制和向动物赋予健康益处的方法
WO2020015842A1 (en) * 2018-07-18 2020-01-23 Michalsen Andreas Effects of a short-term fasting mimicking diet on quality of life and tolerance to chemotherapy in patients with cancer
JP2022515707A (ja) * 2018-11-09 2022-02-22 エル－ニュートラ 断続的断食模倣のための栄養バー
KR20210043895A (ko) 2019-10-14 2021-04-22 주식회사 엘지화학 전기화학소자용 분리막의 절연 및 리튬 이온전도도 특성 평가 방법 및 시스템
IT202000008740A1 (it) * 2020-04-23 2021-10-23 L Nutra Inc Composizione dietetica per l’incremento della massa magra e della massa muscolare
CN111759883B (zh) * 2020-07-23 2021-09-17 浙江农林大学 山核桃内果皮提取物在制备抗卵巢癌产品中的应用
CN115120609B (zh) * 2022-06-21 2023-08-08 无限极（中国）有限公司 一种抑制雌激素表达以及保护乳腺的中药多糖组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8865646B2 (en) * 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
EP2490684B1 (en) 2009-10-22 2018-01-03 University Of Southern California Methods and nutritional formulations to increase the efficacy and reduce the side effects of cancer treatment
EP2563398B1 (en) 2010-04-28 2017-04-19 University of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
RU2438662C1 (ru) * 2010-07-16 2012-01-10 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ лечения доброкачественных гиперпластических процессов эндометрия у больных метаболическим синдромом
EP2909802B1 (en) 2012-10-22 2020-08-12 University of Southern California Diet formulations promoting tissue/organ regeneration
CN109187991B (zh) * 2013-02-12 2021-12-24 南加利福尼亚大学 为受试者提供合理蛋白质膳食的方法
DE202014011516U1 (de) * 2013-07-01 2021-09-16 University Of Southern California Diätpaket
CA2984891A1 (en) * 2015-05-06 2016-11-10 University Of Southern California Fasting mimicking and enhancing diet for treating hypertension and lipid disorders
ITUB20160828A1 (it) 2016-02-18 2017-08-18 Univ Degli Studi Genova Utilizzo di una dieta che mima il digiuno per potenziare l'efficacia di antiestrogeni nella terapia del cancro

Also Published As

Publication number Publication date
CA3051634A1 (en) 2018-08-02
AU2018212440A1 (en) 2019-06-20
KR20190126783A (ko) 2019-11-12
IT201700008499A1 (it) 2018-07-26
WO2018138090A1 (en) 2018-08-02
EP3573481A1 (en) 2019-12-04
EP3573481B1 (en) 2022-04-20
JP2020505921A (ja) 2020-02-27
US20190380373A1 (en) 2019-12-19
RU2019116827A (ru) 2021-02-26
CN110402087A (zh) 2019-11-01
BR112019015302A2 (pt) 2020-03-03

Similar Documents

Publication Publication Date Title
MX2019008589A (es) Composicion de dieta para la prevencion y/o el tratamiento para la hiperplasia endometrial.
MX2022005323A (es) Novedosos lactobacillus que tienen diversas funciones, y uso de los mismos.
NZ715431A (en) Fasting condition as dietary treatment of diabetes
MY202018A (en) Anti-cd39 antibodies, compositions comprising anti-cd39 antibodies and methods of using anti-cd39 antibodies
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
SG10201902664RA (en) Combination therapy for treating cancer
MX2021001807A (es) Combinacion de un inhibidor de histona desacetilasa y un inhibidor de proteina cinasa y uso farmaceutico de la misma.
MY185981A (en) Glycoside compositions
BR112015022306A2 (pt) adoçante aperfeiçoado
AU2016304856A8 (en) Mechanism of resistance to BET bromodomain inhibitors
MX2018002546A (es) Composiciones que comprenden un compuesto de urolitina.
BR112017014107A2 (pt) composição nutricional útil no tratamento de pacientes com ibd
MX2018002543A (es) Composiciones que comprenden compuestos de urolitina.
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
PH12019501295A1 (en) Nutritional compositions containing butyrate and/or lactoferrin and uses thereof
WO2018025080A3 (en) Compositions for enhancing brain activity
WO2019090182A3 (en) Glycan preparations and methods of use for hyperammonemia
SG10201811109PA (en) Methods of treating ttp with immunoglobulin single variable domains and uses thereof
MY197917A (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
HUE060933T2 (hu) 2'-fukozil-laktózt és élelmi butirátot tartalmazó táplálékkészítmény
MX2021005534A (es) Metodos para aumentar la oxidacion de grasa o el gasto de energia o la saciedad en un animal.
SG10201807034XA (en) A pharmaceutical composition for improving or preventing progression of Chronic Kidney Disease
IL278009B1 (en) History of 6,2-diamino-4,3-dihydropyrimidin-4-one and its use in treatment
MX2020008082A (es) Compuestos y composiciones para el tratamiento del dolor.
EP3871681A4 (en) TYPE 1 HELPER T LYMPHOCYTE AUGMENTANT, FOOD AND MEDICINE